Marksans Pharma Ltd.: Share Price, Stock Analysis, Annual Report | Value Research Get Marksans Pharma Ltd.'s stock analysis, price valuation, corporate actions, and financials from India's independent mutual fund research house.
info-circle
MARKSANS

Click to see a quick summary and important updates about this stock!Dismiss

Marksans Pharma Ltd.

BSE: 524404, NSE: MARKSANS

  • Market Capitalisation info

    ₹2,461 Cr


  • 12 Month Earnings info

    ₹199 Cr

  • Price to Earnings info

    12.37

₹61.10

As on 05-Dec-2022 IST

up-down-arrow2.754.71%

  • Prev Close info

    58.35

  • Day's Openinfo

    58.60

  • Today's Highinfo

    61.50

  • Today's Lowinfo

    58.40

  • Today's Volumeinfo

    35,08,439

Please wait...

Stock Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Marksans Pharma
1.58 20.04 15.94 5.25 62.84 10.61 37.66
S&P BSE Healthcare
-9.13 -1.85 4.73 -5.32 20.65 11.37 11.54
S&P BSE Small Cap
1.79 3.02 4.12 5.50 30.63 10.84 15.05
As on 05-Dec-2022
2021
2020
2019
2018
2017
2016
2015
Marksans Pharma
-1.31 253.64 -40.78 -30.29 0.25 -61.90 66.32
S&P BSE Small Cap
62.77 32.11 -6.85 -23.41 59.64 1.77 6.76
S&P BSE Healthcare
20.87 61.45 -3.55 -5.89 0.49 -12.88 15.06

Valuation

Stock
Peer Median
Please wait...

Growth & Efficiency

Stock
Peer Median
Please wait...

Solvency

Is there a threat to this company's solvency in the future?

Financial Manipulation

Can creative accounting be detected through the financial numbers?

Peer Comparison

search
search
search
search
    Please wait...

    Valuation Chart

      Please wait...
        Please wait...

        Financials

        Please wait...
        Please wait...
        Please wait...

        Shareholding Pattern

        News & Analysis

        No Review & Analysis are available.

        Other Details

        Incorporated

        1992

        Chairman

        Mark Saldanha

        Managing Director

        Mark Saldanha

        Headquarters

        Mumbai, Maharashtra
        Edit edit
        Please wait...
        Please wait...
        Please wait...
        Please wait...

        Key Facts

        • Market cap info

          ₹2,460.52 Cr

        • Revenue (TTM) info

          ₹1,667.01 Cr

        • Earnings (TTM) info

          ₹198.89 Cr

        • Cash info

          ₹335.39 Cr

        • Total Debt info

          ₹41.29 Cr

        • Promoters' ownership info

          48.60%

        • Liquidity info

          High

        • 52 Week range info

          ₹38.60 - 65.00

        • Face value info

          ₹1.00

        • Shares outstanding info

          40,30,34,114

        • 10 Years Aggregate:

          CFO: ₹891.43 Cr

          EBITDA: ₹1,525.79 Cr

          Net Profit: ₹990.83 Cr

        About The Company

        • Business

          Manufacture of pharmaceuticals, medicinal chemical and botanical products

        • Incorporated

          1992

        • Chairman

          Mark Saldanha

        • Managing Director

          Mark Saldanha

        • Listing info

          BSE: 524404, NSE: MARKSANS

        • Country

          India

        • Headquarters info

          Mumbai, Maharashtra

        • Website info

          www.marksanspharma.com